Connection

ANITA SABICHI to Neoplasm Grading

This is a "connection" page, showing publications ANITA SABICHI has written about Neoplasm Grading.
Connection Strength

0.087
  1. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila). 2011 Oct; 4(10):1580-9.
    View in: PubMed
    Score: 0.087
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.